Safety and Immunogenicity of Cell-culture Non-adjuvanted and MF59-adjuvanted Influenza H1N1 Vaccines in Healthy Adults
Phase of Trial: Phase I
Latest Information Update: 28 Jul 2015
At a glance
- Drugs Influenza A virus vaccine-H1N1 (Primary)
- Indications Influenza A virus H1N1 subtype
- Focus Pharmacodynamics
- 07 Aug 2012 Actual end date changed from 28 Jul 2009 to 1 Dec 2009 as reported by ClinicalTrials.gov.
- 19 Jan 2010 Results were presented in the New England Journal of Medicine.
- 17 Dec 2009 Results were published in the New England Journal of Medicine.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History